Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years

Area of Science:

• Immunology
• Vaccinology
• Pediatrics

Background:

• The meningococcal C conjugate vaccine (MCC) is crucial for preventing meningococcal disease.
• Some children may not mount an adequate initial antibody response to MCC.
• Assessing immune memory is important for understanding vaccine effectiveness.

Purpose of the Study:

• To evaluate the immunologic response in children with a prior non-response to MCC.
• To determine if a booster dose elicits a secondary immune response.

Main Methods:

• Fourteen children, initially unresponsive to MCC at age 4, received a booster dose at age 6.
• Bactericidal antibody titers were measured 7 and 14 days post-booster immunization.

Main Results:

• A rapid and substantial increase (1000-fold) in bactericidal antibody titers was observed post-booster.
• This significant rise suggests the presence of immunological memory.

Conclusions:

• Children who do not respond to the primary dose of MCC may still possess immunological memory.
• A booster dose can effectively elicit a strong secondary antibody response in such children.
• This highlights the importance of booster vaccinations for comprehensive protection.